Our Goal

To generate at least one mechanistically distinct TB drug candidate per year with the goal of advancing at least one universal drug regimen to a one-month clinical proof of concept.

Current TB regimens drive down bacterial levels quickly, but require months of treatment to rid the body of all TB.

The only way to overcome this persistence is thorough a shorter, more effective regimen.